Our mission is to develop and produce innovative prophylactic and therapeutic vaccines to protect against major infectious and non-infectious diseases.
We consider R&D and business development collaborations to be a key way of doing this. They serve to strengthen the excellence of research within the company and in the wider scientific community.
We are keen to continue to build on our strong network of collaborations, strategic alliances and joint ventures in manufacturing, commercial operations and R&D. Our current partners include large pharmaceutical companies, small biotech businesses, consortia, governments, charities and academia (including graduate and post-doctoral research programmes).
Our partners have the opportunity to share in our commitment to finding solutions for:
- antigen design and selection
- vaccine formulations
- adjuvant development
- manufacturing methods
Partners also benefit from our:
- scientific expertise
- experience of health economics
- commercialisation strategies and global reach
- experience in improving patient access to vaccines
If you have a promising new scientific concept, product or technology - around either therapeutic or prophylactic vaccines - we will provide direct access to our scientists and give your idea the attention it deserves.
For more specific information on what we are looking for, take a look at our areas of interest.
If you are interested in working with us or would like more information, please email us at email@example.com
We know that many great ideas can come from outside of GSK, and collaborating with other companies, organisations and academics is fundamental to our business strategy
Our areas of interest
Find out about the key therapeutic areas we are interested in collaborating on
Find out how we work with academic institutions, and what we offer in terms of mutual benefits to research partner
We are seeking to grow and integrate a research network that will become a new bioelectronics community